These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22834000)

  • 1. Drug delivery to the Lungs 21.
    Mitchell JP; Nichols SC
    Ther Deliv; 2011 Mar; 2(3):301-5. PubMed ID: 22834000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
    Muralidharan P; Hayes D; Mansour HM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery Technologies for Orally Inhaled Products: an Update.
    Moon C; Smyth HDC; Watts AB; Williams RO
    AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro and in vivo investigation of inhaled migraine therapies using a novel aerosol delivery system consisting of an air pressurized capsule device (APCD) in combination with a pMDI spacer for endotracheal dosing into beagle dogs.
    Sellers S; Horodnik W; House A; Wylie J; Mauser P; Garber N; Pu YE; Berry J; Donovan B
    Drug Dev Ind Pharm; 2015; 41(12):1989-96. PubMed ID: 25986873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation techniques for high dose dry powders.
    Brunaugh AD; Smyth HDC
    Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
    Walenga RL; Longest PW
    J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device factors affecting pulmonary delivery of dry powders.
    Smutney CC; Grant M; Kinsey PS
    Ther Deliv; 2013 Aug; 4(8):939-49. PubMed ID: 23919473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing and advancing dry powder inhalation towards enhanced therapeutics.
    Stegemann S; Kopp S; Borchard G; Shah VP; Senel S; Dubey R; Urbanetz N; Cittero M; Schoubben A; Hippchen C; Cade D; Fuglsang A; Morais J; Borgström L; Farshi F; Seyfang KH; Hermann R; van de Putte A; Klebovich I; Hincal A
    Eur J Pharm Sci; 2013 Jan; 48(1-2):181-94. PubMed ID: 23142635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The History of Therapeutic Aerosols: A Chronological Review.
    Stein SW; Thiel CG
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):20-41. PubMed ID: 27748638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled gene delivery: a formulation and delivery approach.
    Gomes Dos Reis L; Svolos M; Hartwig B; Windhab N; Young PM; Traini D
    Expert Opin Drug Deliv; 2017 Mar; 14(3):319-330. PubMed ID: 27426972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry powder inhalation: past, present and future.
    de Boer AH; Hagedoorn P; Hoppentocht M; Buttini F; Grasmeijer F; Frijlink HW
    Expert Opin Drug Deliv; 2017 Apr; 14(4):499-512. PubMed ID: 27534768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
    Rawal T; Kremer L; Halloum I; Butani S
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulizers for drug delivery to the lungs.
    Martin AR; Finlay WH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):889-900. PubMed ID: 25534396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary drug delivery: novel pharmaceutical technologies breathe new life into the lungs.
    Nanjwade BK; Adichwal SA; Gaikwad KR; Parikh KA; Manvi FV
    PDA J Pharm Sci Technol; 2011; 65(5):513-34. PubMed ID: 22293840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of abbreviated impactor measurement workshop organized by the European Pharmaceutical Aerosol Group.
    Mitchell JP; Nichols SC
    Ther Deliv; 2011 Mar; 2(3):307-10. PubMed ID: 22834001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.
    Wilson EM; Luft JC; DeSimone JM
    Pharm Res; 2018 Aug; 35(10):195. PubMed ID: 30141117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
    Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
    Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.